Urihk Pharmaceuticals
  • Home
  • About Us
    • Our Team
    • The Urihk Partnership
  • Products
    • Antibiotic
    • Antifungal
    • Anticoagulant
    • Immuno modulator
    • Neuro/CNS
  • Services
  • Learn More
    • News
    • Gallery
    • Careers
  • Contact Us
Select Page
Back
Prevention of progression of cognitive decline in the first-degree relatives of patients with Alzheimer’s disease
Oct 25, 2021

Prevention of progression of cognitive decline in the first-degree relatives of patients with Alzheimer’s disease

A retrospective, multi-centre cohort study evaluating the severity- related effects of cerebrolysin /Cerebroprotein Hydrolysate treatment on clinical outcomes in traumatic brain injury
Oct 25, 2021

A retrospective, multi-centre cohort study evaluating the severity- related effects of cerebrolysin /Cerebroprotein Hydrolysate treatment on clinical outcomes in traumatic brain injury

Cerebrolysin and Recovery After Stroke (CARS)
Oct 25, 2021

Cerebrolysin and Recovery After Stroke (CARS)

ABOUT URIHK

URIHK pharmaceuticals is a wholly owned subsidiary of UREKA Hong Kong Ltd. We are a vertically integrated pharmaceutical company that launches, registers and distributes innovative products in India.

 

SITEMAP

  • About Us
  • Services
  • Products
  • Careers
  • Privacy Policy

CONTACT US

602-603, Sai Samarth Business Park,
Deonar, Govandi (East),
Mumbai (400088), India

Phone: +91 22 497 01103 / 43286

Email: [email protected]